Evidence map›Paper›PMID 11313816›Full record

ArticleGene therapy2001

Targeted gene correction by small single-stranded oligonucleotides in mammalian cells.

O Igoucheva, V Alexeev, K Yoon

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Review
  3. Cleavage-free human genome editing.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  4. Differential Interactions of Chiral Nanocapsules with DNA.International journal of molecular sciences · 2021
    Article
  5. Article
  6. Article
  7. Beyond editing to writing large genomes.Nature reviews. Genetics · 2017
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Horizontal transfer of short and degraded DNA has evolutionary implications for microbes and eukaryotic sexual reproduction.BioEssays : news and reviews in molecular, cellular and developmental biology · 2014
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

O IgouchevaDepartment of Dermatology and Cutaneous Biology, Department of Biochemistry and Molecular Pharmacology, Jefferson Institute of Molecular Medicine, Thomas Jefferson University and Jefferson Medical College, Philadelphia, PA 19107, USA.
V Alexeev
K Yoon
Jefferson Institute · USThomas Jefferson University · US

Funding

TRANSGENIC MICE WITH EPIDERMOLYSIS BULLOSAP01AR038923 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI UITTO, JOUNI · 1987 to 2006
$7.8M
NEW GENE THERAPY FOR RHEUMATOID ARTHRITISR01AR044350 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI YOON, KYONGGEUN · 1997 to 1999
–
NIAMS NIH HHS P0 AR38923NIAMS NIH HHS R0 AR44350
6 · The paper itself

Abstract

We demonstrate that relatively short single-stranded oligodeoxynucleotides, 25-61 bases homologous to the target sequence except for a single mismatch to the targeted base, are capable of correcting a single point mutation (G to A) in the mutant beta-galactosidase gene, in nuclear extracts, episome, and chromosome of mammalian cells, with correction rates of approximately 0.05%, 1% and 0.1%, respectively. Surprisingly, these short single-stranded oligonucleotides (ODN) showed a similar gene correction frequency to chimeric RNA-DNA oligonucleotide, measured using the same system. The in vitro gene correction induced by ODN in nuclear extracts was not dependent on the length or polarity of the oligonucleotide. In contrast, the episomal and chromosomal gene corrections were highly dependent on the ODN length and polarity. ODN with a homology of 45 nucleotides showed the highest frequency and ODN with antisense orientation showed a 1000-fold higher frequency than sense orientation, indicating a possible influence of transcription on gene correction. Deoxyoligonucleotides showed a higher frequency of gene correction than ribo-oligonucleotides of the identical sequence. These results show that a relatively short ODN can make a sequence-specific change in the target sequence in mammalian cells, at a similar frequency as the chimeric RNA-DNA oligonucleotide.

Indexed as

Point MutationAnimalsBase Pair MismatchBase Sequencebeta-GalactosidaseCHO CellsCricetinaeDNA RepairDNA, SuperhelicalGene TargetingGenetic TherapyMolecular Sequence DataOligonucleotidesPlasmidsPolymorphism, Restriction Fragment LengthTransfectionbeta-GalactosidaseDNA, SuperhelicalOligonucleotides

Identifiers

PMID11313816
OpenAlexW1965606872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.